A carregar...
PCA3 and TMPRSS2-ERG gene fusions as diagnostic biomarkers for prostate cancer
The incidence of prostate cancer (PCa) is rising steadily among males in many countries. Serum prostate-specific antigen (PSA) is widely applied to clinical diagnosis and screening of PCa. However, the so-called grey area of PSA levels 4.0–10.0 ng/mL has a low specificity of 25–40% resulting in a hi...
Na minha lista:
Publicado no: | Chin J Cancer Res |
---|---|
Main Authors: | , , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
AME Publishing Company
2016
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4779752/ https://ncbi.nlm.nih.gov/pubmed/27041928 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3978/j.issn.1000-9604.2016.01.05 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|